Constipation on GLP-1 Treatment: What Is Common and When to Seek Help

By Dr Bianca Crook, South African general practitioner
Medically reviewed: 1 September 2026

Constipation is a recognised side effect of several GLP-1 and GIP/GLP-1 medicines. Mild symptoms may improve with fluids, appropriate fibre, movement and a clinician-approved bowel plan. Severe pain, repeated vomiting, a swollen abdomen, inability to pass stool or gas, blood in the stool, fever or rapid worsening needs prompt medical assessment.

Key points

  • Do not wait until constipation is severe before mentioning it.
  • Increase fibre carefully; adding a large amount without enough fluid can make symptoms worse.
  • Persistent vomiting or inability to keep fluids down raises dehydration risk.
  • Severe abdominal symptoms should not be assumed to be “just the injection.”
  • Ask before using laxatives if you have significant pain, vomiting, kidney disease, pregnancy or other medical concerns.

Why constipation can happen

GLP-1 medicines influence appetite and gastrointestinal function. Some people eat smaller quantities, drink less because they feel full, reduce their usual fibre intake, or move less when they feel nauseated. The medicine may also slow digestive transit. These factors can combine.

Constipation can mean fewer bowel movements than usual, hard or lumpy stool, straining, a feeling of incomplete emptying, or needing more effort to pass stool. The person’s normal pattern matters; there is no single number of bowel movements that defines the problem for everyone.

Start with a careful review

If symptoms are mild, consider what changed around the same time. Are you drinking less? Has your food volume fallen sharply? Are you eating enough fibre-containing foods? Are iron tablets, opioid pain medicines, anticholinergic medicines or other treatments contributing? Has activity decreased? Did symptoms worsen after a GLP-1 dose increase?

Share these details with the prescriber or pharmacist. They help distinguish routine constipation from a problem that needs examination or a change in treatment.

Practical measures for mild symptoms

Hydration is a useful starting point unless a clinician has restricted your fluid intake because of heart, kidney or another condition. Sip regularly rather than trying to drink a large amount at once when nausea or fullness is present.

Fibre can help, but it should be increased gradually. Vegetables, fruit, legumes, whole grains and certain seeds may contribute. A sudden large fibre increase without enough fluid may worsen bloating or discomfort. If food intake is very limited, a dietitian or clinician can help balance fibre with protein and overall nutrition.

Regular movement, even gentle walking if medically appropriate, can support bowel function. A consistent opportunity to use the toilet after a meal may also help. Avoid repeatedly ignoring the urge to pass stool.

Some people need an over-the-counter bowel medicine. The right choice depends on the pattern of symptoms, other medicines, pregnancy status, kidney function and local availability. Ask a pharmacist or clinician rather than layering several products together. Stimulant, osmotic and bulk-forming medicines are not interchangeable, and severe abdominal pain or vomiting should be assessed before self-treatment.

When to contact the prescriber

Contact the treatment team when constipation is persistent, worsening, painful, interfering with eating, or recurring after each dose. Also call if you need repeated rescue medicines, have a history of bowel disease, or are unsure whether to proceed with the next scheduled dose.

The clinician may review hydration, diet, other medicines, the GLP-1 dose and timing, and whether another cause is possible. The solution is not automatically to stop treatment, but it is also not automatically to continue unchanged.

If the symptoms began after an increase, read Why the GLP-1 Dose Is Not a Competition. A slower, clinician-led plan may be more appropriate than pushing ahead.

Red flags that need urgent assessment

Seek urgent medical help for severe or steadily worsening abdominal pain, repeated vomiting, inability to keep fluids down, a markedly swollen or tender abdomen, inability to pass stool or gas, fainting, confusion, signs of severe dehydration, black stool, or visible blood in the stool. Fever with significant abdominal symptoms also needs assessment.

Upper abdominal pain that is severe, persistent or radiates to the back can be a warning sign of pancreatitis. Right-upper abdominal pain, fever or jaundice can suggest gallbladder or biliary disease. These conditions cannot be diagnosed from symptoms alone, but they should not be managed as ordinary constipation at home.

Read GLP-1 Red Flags: Symptoms You Should Not Ignore and keep your local emergency contact details available.

Prevent the cycle at the next review

Constipation management works best when discussed before the next dose increase. Ask what bowel pattern should trigger a call, how hydration and fibre should be adapted, and what medicine is safe for you if symptoms recur. Bring a short record of bowel movements, pain, vomiting, fluid intake and dose dates if that helps the consultation.

The goal is not to tolerate escalating symptoms for the sake of weight loss. Safe treatment must remain compatible with hydration, nutrition and daily function.

For a fuller semaglutide and tirzepatide patient guide, including reflux, abdominal pain, dose decisions and urgent warning signs, see Before Your Next Injection.

Medical disclaimer: This article provides general information and cannot determine the cause of abdominal or bowel symptoms. Severe or rapidly worsening symptoms require medical assessment. Do not change or repeat a prescription dose without your healthcare professional.

Sources: FDA Wegovy prescribing information; FDA Zepbound prescribing information; EMA Wegovy product information; WHO GLP-1 therapies Q&A.